A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma

NCT02210182 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Oral Pentamidine
OTHER: Placebo

Sponsor

Oncozyme Pharma Inc.